Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Dr. Reddy's Laboratories Limited
  6. Summary
    500124   INE089A01023

DR. REDDY'S LABORATORIES LIMITED

(500124)
  Report
End-of-day quote. End-of-day quote Bombay Stock Exchange - 12/03
4598 INR   -1.38%
12/03Asian ADRs Decline in Friday Trading
MT
12/03Indian shares surrender early gains on Omicron worries
RE
12/01Asian ADRs Climb Higher in Wednesday Trading
MT
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
4697.15 4681.15 4607.25 4662.45 4598 Last
29903 11475 12991 8346 11228 Volume
-1.01% -0.34% -1.58% +1.20% -1.38% Change
Estimated financial data (e)
Sales 2022 215 B 2 845 M 2 845 M
Net income 2022 29 442 M 390 M 390 M
Net cash position 2022 16 025 M 212 M 212 M
P/E ratio 2022 25,9x
Yield 2022 0,62%
Sales 2023 241 B 3 194 M 3 194 M
Net income 2023 36 862 M 489 M 489 M
Net cash position 2023 37 989 M 504 M 504 M
P/E ratio 2023 20,7x
Yield 2023 0,68%
Capitalization 763 B 10 137 M 10 114 M
EV / Sales 2022 3,48x
EV / Sales 2023 3,01x
Nbr of Employees 22 739
Free-Float 66,7%
More Financials
Company
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed... 
Sector
Pharmaceuticals
Calendar
02/03Earnings Release
More about the company
Ratings of Dr. Reddy's Laboratories Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about DR. REDDY'S LABORATORIES LIMITED
12/03Asian ADRs Decline in Friday Trading
MT
12/03Indian shares surrender early gains on Omicron worries
RE
12/01Asian ADRs Climb Higher in Wednesday Trading
MT
11/30Asian ADRs Move Lower in Tuesday Trading
MT
11/30Dr Reddy's Laboratories Plans to Export Sputnik COVID-19 Vaccine from India
MT
11/29Asian ADRs Nudge Lower in Monday Trading
MT
11/29Indian firm Dr. Reddy's eyes Sputnik vaccine exports after domestic struggle
RE
11/26Asian ADRs Tumble in Friday Trading
MT
11/26Indian Indices End Lower on Friday; JSW Steel Plunges 8%
MT
11/26Indian shares drop most in 7 months on fears over new virus variant
RE
11/19Asian ADRs Move Higher in Friday Trading
MT
11/18Asian ADRs Move Sharply Lower in Thursday Trading
MT
11/16Asian ADRs Nudge Higher in Tuesday Trading
MT
11/15Asian ADRs Slightly Lower Monday Morning
MT
11/08Intimation – filing of Form 6k for Q2 FY22 dated November 6, 2021 - Form 6-K
PU
More news
News in other languages on DR. REDDY'S LABORATORIES LIMITED
12/03Baisse des ADR asiatiques dans les échanges de vendredi
12/03Les actions indiennes abandonnent leurs gains initiaux en raison des inquiétudes liées ..
12/01Les ADR asiatiques grimpent dans les échanges de mercredi
11/30Les ADR asiatiques en baisse dans les échanges de mardi
11/29Les ADR asiatiques en baisse dans les échanges de lundi
More news
Analyst Recommendations on DR. REDDY'S LABORATORIES LIMITED
More recommendations
Chart DR. REDDY'S LABORATORIES LIMITED
Duration : Period :
Dr. Reddy's Laboratories Limited Technical Analysis Chart | 500124 | INE089A01023 | MarketScreener
Technical analysis trends DR. REDDY'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 34
Last Close Price 4 598,00 INR
Average target price 5 477,68 INR
Spread / Average Target 19,1%
EPS Revisions
Managers and Directors
Erez Israeli Chief Executive Officer
Parag Agarwal Chief Financial Officer
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Mukesh Rathi Chief Digital & Information Officer
Sector and Competitors
1st jan.Capi. (M$)
DR. REDDY'S LABORATORIES LIMITED-11.65%10 137
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
PFIZER, INC.44.09%304 610
NOVO NORDISK A/S64.51%244 010
ELI LILLY AND COMPANY47.55%222 641